-
1
-
-
0030798861
-
One hundred years of aspirin
-
DOI 10.1016/S0140-6736(97)07087-6
-
Jack DB. One hundred years of aspirin. Lancet 1997; 350: 437-439. (Pubitemid 27331247)
-
(1997)
Lancet
, vol.350
, Issue.9075
, pp. 437-439
-
-
Jack, D.B.1
-
2
-
-
4644289299
-
Platelet-active drugs: The relationships among dose, effectiveness, and side effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
-
Patrono C, Coller B, FitzGerald GA, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 234S-264S.
-
(2004)
Chest
, vol.126
-
-
Patrono, C.1
Coller, B.2
FitzGerald, G.A.3
-
3
-
-
0021163545
-
Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase
-
Pedersen AK, FitzGerald GA. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. N Engl J Med 1984; 311: 1206-1211. (Pubitemid 14021923)
-
(1984)
New England Journal of Medicine
, vol.311
, Issue.19
, pp. 1206-1211
-
-
Pedersen, A.K.1
FitzGerald, G.A.2
-
4
-
-
0019988413
-
Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
-
Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982; 69: 1366-1372. (Pubitemid 12081064)
-
(1982)
Journal of Clinical Investigation
, vol.69
, Issue.6
, pp. 1366-1372
-
-
Patrignani, P.1
Filabozzi, P.2
Patrono, C.3
-
5
-
-
78649723154
-
Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials
-
Soejima H, Morimoto T, Saito Y, et al. Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials. Thromb Haemost 2010; 104: 1085-1088.
-
(2010)
Thromb Haemost
, vol.104
, pp. 1085-1088
-
-
Soejima, H.1
Morimoto, T.2
Saito, Y.3
-
6
-
-
79851495676
-
24-Hour time dependent aspirin efficacy in patients with stable coronary artery disease
-
Henry P, Vermillet A, Boval B, et al. 24-hour time dependent aspirin efficacy in patients with stable coronary artery disease. Thromb Haemost 2010; 105: 336-344.
-
(2010)
Thromb Haemost
, vol.105
, pp. 336-344
-
-
Henry, P.1
Vermillet, A.2
Boval, B.3
-
7
-
-
33645745392
-
Dose- and time-dependent antiplatelet effects of aspirin
-
Perneby C, Wallen NH, Rooney C, et al. Dose- and time-dependent antiplatelet effects of aspirin. Thromb Haemost 2006; 95: 652-658.
-
(2006)
Thromb Haemost
, vol.95
, pp. 652-658
-
-
Perneby, C.1
Wallen, N.H.2
Rooney, C.3
-
8
-
-
79851505904
-
Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease
-
epub ahead of print
-
Lordkipanidze M, Pharand C, Schampaert E, et al. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease. Int J Cardiol 2010; epub ahead of print.
-
(2010)
Int J Cardiol
-
-
Lordkipanidze, M.1
Pharand, C.2
Schampaert, E.3
-
10
-
-
77649228280
-
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: Implications for antiplatelet therapy
-
Dragani A, Pascale S, Recchiuti A, et al. The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. Blood 2010; 115: 1054-1061.
-
(2010)
Blood
, vol.115
, pp. 1054-1061
-
-
Dragani, A.1
Pascale, S.2
Recchiuti, A.3
-
11
-
-
60849111109
-
Immature platelets in patients with acute coronary syndromes
-
Grove EL, Hvas AM, Kristensen SD. Immature platelets in patients with acute coronary syndromes. Thromb Haemost 2009; 101: 151-156.
-
(2009)
Thromb Haemost
, vol.101
, pp. 151-156
-
-
Grove, E.L.1
Hvas, A.M.2
Kristensen, S.D.3
-
12
-
-
78650952436
-
Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease
-
epub ahead of print
-
Grove EL, Hvas AM, Mortensen SB, et al. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost 2010; epub ahead of print.
-
(2010)
J Thromb Haemost
-
-
Grove, E.L.1
Hvas, A.M.2
Mortensen, S.B.3
-
13
-
-
43949115561
-
Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy
-
Cesari F, Marcucci R, Caporale R, et al. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Thromb Haemost 2008; 99: 930-935.
-
(2008)
Thromb Haemost
, vol.99
, pp. 930-935
-
-
Cesari, F.1
Marcucci, R.2
Caporale, R.3
-
14
-
-
79851488675
-
Variability in the recovery rate of platelet cyclooxygenase activity during chronic therapy with low-dose aspirin in type 2 diabetes
-
Abstract
-
Rocca B, Santilli F, Pitocco D, et al. Variability in the recovery rate of platelet cyclooxygenase activity during chronic therapy with low-dose aspirin in type 2 diabetes. Circulation 2010; 122: A12233 (Abstract).
-
(2010)
Circulation
, vol.122
-
-
Rocca, B.1
Santilli, F.2
Pitocco, D.3
-
15
-
-
79851480288
-
Better platelet inhibition in whole blood is achieved by twice daily dosing of aspirin in patients with type 2 diabetes mellitus
-
Abstract
-
Spectre G, Arnetz L, Stalesen R, et al. Better platelet inhibition in whole blood is achieved by twice daily dosing of aspirin in patients with type 2 diabetes mellitus. Circulation 2010; 122: A15018 (Abstract).
-
(2010)
Circulation
, vol.122
-
-
Spectre, G.1
Arnetz, L.2
Stalesen, R.3
-
16
-
-
77953160638
-
A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease
-
Grove EL, Hvas AM, Johnsen HL, et al. A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. Thromb Haemost 2010; 103: 1245-1253.
-
(2010)
Thromb Haemost
, vol.103
, pp. 1245-1253
-
-
Grove, E.L.1
Hvas, A.M.2
Johnsen, H.L.3
-
17
-
-
70350441936
-
Response to aspirin in healthy individuals. Crosscomparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2)
-
Blais N, Pharand C, Lordkipanidze M, et al. Response to aspirin in healthy individuals. Crosscomparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Thromb Haemost 2009; 102: 404-411.
-
(2009)
Thromb Haemost
, vol.102
, pp. 404-411
-
-
Blais, N.1
Pharand, C.2
Lordkipanidze, M.3
-
18
-
-
77749289650
-
Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery
-
Brambilla M, Parolari A, Camera M, et al. Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery. Thromb Haemost 2010; 103: 516-524.
-
(2010)
Thromb Haemost
, vol.103
, pp. 516-524
-
-
Brambilla, M.1
Parolari, A.2
Camera, M.3
-
19
-
-
74249123585
-
Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients
-
Mateos-Caceres PJ, Macaya C, Azcona L, et al. Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients. Thromb Haemost 2010; 103: 160-170.
-
(2010)
Thromb Haemost
, vol.103
, pp. 160-170
-
-
Mateos-Caceres, P.J.1
Macaya, C.2
Azcona, L.3
-
20
-
-
64849112905
-
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin
-
Pettinella C, Romano M, Stuppia L, et al. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. Thromb Haemost 2009; 101: 687-690.
-
(2009)
Thromb Haemost
, vol.101
, pp. 687-690
-
-
Pettinella, C.1
Romano, M.2
Stuppia, L.3
|